Ocular toxicity assessment of chronic sildenafil therapy for pulmonary arterial hypertension.

about

Ocular toxicity assessment of chronic sildenafil therapy for pulmonary arterial hypertension.

Item

http://www.wikidata.org/entity/Q53119168

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Ocular toxicity assessment of ...... lmonary arterial hypertension.

@en

Ocular toxicity assessment of ...... lmonary arterial hypertension.

@nl

type

Item

label

Ocular toxicity assessment of ...... lmonary arterial hypertension.

@en

Ocular toxicity assessment of ...... lmonary arterial hypertension.

@nl

prefLabel

Ocular toxicity assessment of ...... lmonary arterial hypertension.

@en

Ocular toxicity assessment of ...... lmonary arterial hypertension.

@nl

P1476

Ocular toxicity assessment of ...... ulmonary arterial hypertension

@en

P2093

Denise de Freitas

http://www.w3.org/2001/XMLSchema#string

Elisabeth Nogueira Martins

http://www.w3.org/2001/XMLSchema#string

Flavio E Hirai

http://www.w3.org/2001/XMLSchema#string

Licia Matieli

http://www.w3.org/2001/XMLSchema#string

Maira S A Morales

http://www.w3.org/2001/XMLSchema#string

Norma Allemann

http://www.w3.org/2001/XMLSchema#string

Solange Rios Salomão

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study.

Sildenafil (Viagra) and ophthalmology.

Sildenafil citrate therapy for pulmonary arterial hypertension.

Vision disorders and phosphodiesterase type 5 inhibitors: a review of the evidence to date.

Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension.

Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension.

Evaluation of pulmonary arterial hypertension.

Gender and ocular manifestations of connective tissue diseases and systemic vasculitides.

Pulmonary arterial hypertension in women.

Ophthalmic adverse drug reactions to systemic drugs: a systematic review.

P2888

s00417-016-3352-8

P304

1167-1174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00417-016-3352-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

254

http://www.w3.org/2001/XMLSchema#string

P50

Adriana Berezovsky

Jaquelina Ota-Arakaki

P577

2016-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27094700

http://www.w3.org/2001/XMLSchema#string